| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 2.690.b | Amgros I/S | Sandoz A/S, Accord Healthcare AB, 2care4 ApS, Sandoz A/S, Accord Healthcare AB, Sandoz A/S, Sandoz A/S, Orifarm Generics A/S, STADA Nordic ApS, Sandoz A/S, Sandoz A/S, Viatris ApS, Sandoz A/S, Teva Denmark A/S, Haleon Denmark ApS, Orifarm Generics A/S, Zentiva Denmark ApS, Medical Valley Invest AB, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, Medical Valley Invest AB, Orifarm Generics A/S, Sandoz A/S, Mundipharma A/S, 2care4 ApS, Teva Denmark A/S, Orifarm Generics A/S, Teva Denmark A/S, Mundipharma A/S, Orifarm Generics A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, Teva Denmark A/S, Teva Denmark A/S, Mundipharma A/S, Teva Denmark A/S, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag | 102.193.408 kr. | 25. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 1.603.a | Amgros I/S | G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, G.L. Pharma Nordic Aktiebolag, Haleon Denmark ApS, Haleon Denmark ApS, Haleon Denmark ApS, Mundipharma A/S, Mundipharma A/S, Abcur AB, Abcur AB, Mundipharma A/S, Hameln Pharma ApS, Hameln Pharma ApS, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Jazz Pharmaceuticals Denmark ApS | 148.245.484 kr. | 21. oktober 2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, Chiesi Pharma AB, AstraZeneca A/S, Boehringer Ingelheim Danmark A/S | 44.368.590 kr. | 13. oktober 2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, Chiesi Pharma AB, AstraZeneca A/S, Boehringer Ingelheim Danmark A/S | 44.368.590 kr. | 13. oktober 2026 |
| Amgros 2027 2.213.a | Amgros I/S | Orifarm A/S, Mundipharma A/S, Mundipharma A/S, Mundipharma A/S, Abacus Medicine A/S, Boehringer Ingelheim Danmark A/S, Chiesi Pharma AB, Chiesi Pharma AB, AstraZeneca A/S, Boehringer Ingelheim Danmark A/S | 44.368.590 kr. | 13. oktober 2026 |